Cargando…
Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists
There is an unmet need for effective pharmacological therapies for constipation, a symptom that significantly deteriorates patients’ quality of life and impacts health care. Ghrelin is an endogenous ligand for the growth hormone secretagogue receptor and has been shown to exert prokinetic effects on...
Autores principales: | Mosińska, Paula, Zatorski, Hubert, Storr, Martin, Fichna, Jakub |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383112/ https://www.ncbi.nlm.nih.gov/pubmed/28238253 http://dx.doi.org/10.5056/jnm16183 |
Ejemplares similares
-
What is the Future of the Gut Microbiota-Related Treatment? Toward Modulation of Microbiota in Preventive and Therapeutic Medicine
por: Zatorski, Hubert, et al.
Publicado: (2014) -
Triphala: current applications and new perspectives on the treatment of functional gastrointestinal disorders
por: Tarasiuk, Aleksandra, et al.
Publicado: (2018) -
Polyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal Cancer
por: Michalak, Arkadiusz, et al.
Publicado: (2016) -
Relamorelin in Gastroparesis and Diabetic Gastroparesis: A Meta-Analysis on Its Efficacy and Safety
por: Patel, Akash, et al.
Publicado: (2023) -
AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice
por: Zatorski, Hubert, et al.
Publicado: (2021)